Dyne Therapeutics Inc (DYN)
Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference
FibroGen Rebrands as Kyntra Bio to Reflect a New Era of Focus and Momentum
Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
Genprex Provides Clinical Update on Diabetes Gene Therapy Program
10x Genomics - CareDx and 10x Genomics to LaunchImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
CareDx - CareDx and 10x Genomics to LaunchImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders